Advertisement

Targeted Approaches Improve Survival in CLL Compared with Chemo-Immunotherapy

Treatment strategies for chronic lymphocytic leukemia (CLL) have shifted away from chemo-immunotherapy-based approaches to more targeted therapeutics. During a presentation at NAMCP 2020 Virtual...

Considerations for IBD Treatment and Barriers to Appropriate Care

Inflammatory bowel disease (IBD; including ulcerative colitis and Crohn’s disease) is a chronic, heterogenous immune-mediated inflammatory disorder, for which early, multidisciplinary interventions to induce and...

Current and Pipeline Treatment Options for Psoriatic Arthritis

Psoriatic arthritis (PsA) occurs in 6% to 41% of patients with psoriasis but goes frequently undiagnosed by dermatologists. However, earlier treatment initiation is beneficial....

Management Strategies for Insomnia

Approximately 30% of the general population experiences insomnia symptoms, and 6% to 10% have symptoms associated with daytime functional impairment. During a presentation at...

A Review of Treatment Options for Metastatic and Non-Metastatic Prostate Cancer

Prostate cancer is the second most common cancer in men, with approximately 1.1 million new cases and 307,000 deaths reported in 2012, making it...
Advertisement